A comprehensive overview of the conceptual background of the cellular models for Luminal A, Luminal B, and aromatase-expressing post-menopausal breast cancer subtypes, current targeted therapeutic options, therapy-resistant stem cells, naturally occurring dietary phytochemicals, and nutritional herbs as therapeutic alternatives for therapy-resistant breast cancer and future research directions are summarized in Table 5. This evidence concerns the gene CYP19A1 and breast carcinoma.